Protea Biosciences Group, Inc. 4
4 · Protea Biosciences Group, Inc. · Filed Feb 13, 2014
Insider Transaction Report
Form 4
POWELL MATTHEW
Dir. R&D; Chief Science Off.
Transactions
- Award
Stock Option
2005-12-15$40000.00/sh+80,000$3,200,000,000→ 80,000 totalExercise: $0.50From: 2005-12-15Exp: 2015-12-15→ Common Stock (80,000 underlying) - Award
Stock Option
2007-01-19$125000.00/sh+100,000$12,500,000,000→ 180,000 totalExercise: $1.25From: 2007-01-19Exp: 2017-01-19→ Common Stock (100,000 underlying) - Award
Stock Option
2009-12-31$60000.00/sh+40,000$2,400,000,000→ 220,000 totalExercise: $1.50From: 2009-12-31Exp: 2019-12-31→ Common Stock (40,000 underlying)
Footnotes (1)
- [F1]Represents shares vested as of February 10, 2014.